期刊文献+

肿瘤患者特殊医学用途配方食品应用专家共识 被引量:31

下载PDF
导出
摘要 2013 年中国肿瘤登记年报显示,全国新发肿瘤病例312 万,死亡肿瘤病例270 万,相当于每小时有356 人被诊断为肿瘤、308 人死于肿瘤;2015年中国肿瘤登记年报显示,全国共有新发肿瘤病例429 万,死亡肿瘤病例281 万,相当于每小时有490 人被诊断为肿瘤、321 人死于肿瘤[1]。比较2013、2015 年报数据发现,我国肿瘤发病率及死亡率均在升高。WHO 预计未来20 年,全世界新发肿瘤病例会增加70%,有近一半出现在亚洲,其中大部分在中国,中国新增肿瘤病例高居全球第一位,全世界24% 的肿瘤死亡患者在中国。肿瘤已经成为我国名副其实的常见疾病,并成为我国居民第一死亡原因。
出处 《肿瘤代谢与营养电子杂志》 2016年第2期95-99,共5页 Electronic Journal of Metabolism and Nutrition of Cancer
  • 相关文献

参考文献32

  • 1Chen W, Zheng R, Baade PD, et al. Cancer statistics in China. CACancer J Clin. 2016;66(2):115-132.
  • 2Guest JF, Panca M, Baeyens JP, et al. Health economic impactof managing patients following a community-based diagnosis ofmalnutrition in the UK. Clin Nutr. 2011;30(4):422-429.
  • 3Philipson TJ, Snider JT, Lakdawalla DN, et al. Impact of oralnutritional supplementation on hospital outcomes. Am J ManagCare. 2013;19(2):121-128.
  • 4石汉平,江华,李薇,等,中国抗癌协会.中国肿瘤营养治疗指南[M].北京:人民卫生出版社,2015.
  • 5Colomer R, Moreno-Nogueira JM, García-Luna PP, et al. N-3 fattyacids, cancer and cachexia: a systematic review of the literature. BrJ Nutr. 2007;97(5):823-831.
  • 6Kubota K, Kuroda J, Yoshida M, et al. Preoperativeoralsupplementation support in patients with esophageal cancer. J NutrHealth Aging. 2014;18(4):437-440.
  • 7Braga M, Wischmeyer PE, Drover J, et al. Clinical evidenceforpharmaconutrition in major elective surgery. JPEN J ParenterEnteral Nutr. 2013;37(5 Suppl):66S-72S.
  • 8石汉平,许红霞,李苏宜,曹伟新,李薇,巴一,陈公琰,王昆华,齐玉梅,陈子华,于康,江华,胡雯,丛明华,陈俊强,李增宁,方玉,葛声,王新颖,林源,管文贤,罗琪.营养不良的五阶梯治疗[J].肿瘤代谢与营养电子杂志,2015,2(1):29-33. 被引量:273
  • 9Bozzetti F, Forbes A. The ESPEN clinical practice Guidelines on Parenteral Nutrition: present status and perspectives for futureresearch. Clin Nutr. 2009;28(4):359-364.
  • 10Yoshikawa T, Hiki N, Taguri M, et al. A phase III trial to evaluatethe effect of perioperative nutrition enriched with eicosapentaenoicacid on body weight loss after total gastrectomy for T2-T4a gastriccancer. Jpn J Clin Oncol. 2012;42(5):459-462.

二级参考文献116

  • 1陈伟,蒋朱明,张永梅,王秀荣,陈春明,史轶蘩.欧洲营养不良风险调查方法在中国住院患者的临床可行性研究[J].中国临床营养杂志,2005,13(3):137-141. 被引量:214
  • 2蔡秀军,张宇华.腹腔镜胃癌根治术现状与展望[J].中国微创外科杂志,2006,6(2):84-86. 被引量:32
  • 3戴寅,傅斌生,魏忠,谢钊,赵旭辉.谷氨酰胺强化的肠内营养在胃癌术后中的应用[J].安徽医学,2006,27(2):100-102. 被引量:4
  • 4Stein CA,Cheng YC.Science,1993,261:1004-10.
  • 5Zamecnik PC,Stephenson ML.Inhibition of Rous sarcoma virus replication and cell transformation byaspecificoligode oxynucleotide.Proc Natl Acad Sci,1978,75:280-284.
  • 6Somer W,Heillig M.Antisense oligonucleotides are clinically tested.They inhibit the expression of disease-related genes.Lakartidnin Gen,1999,55(3):348-354.
  • 7Lee MJ,Cho SS,You JR,et al.Intraper itoneal gene delivery mediated by a novel cationic liposome in a peritoneal disseminated ovarian cancer model.Gene Ther,2002,9(13):859-866.
  • 8Iversen P.In vivo studies with phosphorothioate oligonucleotides:pharmacokine-tics prolgue.Anticancer Drug Des,1991,6:531-8.
  • 9Agrawal S,Temsamani J,Tang JY.Pharmacokinetics,biodistribution and stability of oligodeoxynucleotide phosphorothioates in mice.Proc Natl Acad Sci U.S.A,1991,88:7595-9.
  • 10Whitesell L,Rosolen A,Neckers LM.In vivo modulation of Nmyc expression by continuous perfusion with an antisense oligonucleotide.Antisense Res Dev,1991,1:343-50.

共引文献580

同被引文献288

引证文献31

二级引证文献214

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部